Koers Day One Biopharmaceuticals, Inc.
Aandelen
DAWN
US23954D1090
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,21 USD | -13,03% | -16,13% | -9,52% |
Omzet 2024 * | 13,26 mln. 12,36 mln. | Omzet 2025 * | 86,5 mln. 80,64 mln. | Marktkapitalisatie | 1,15 mld. 1,08 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -228 mln. -213 mln. | Nettowinst (verlies) 2025 * | -177 mln. -165 mln. | EV/omzet 2024 * | 80 x |
Nettoliquiditeiten 2024 * | 93,43 mln. 87,1 mln. | Nettoliquiditeiten 2025 * | 219 mln. 205 mln. | EV/omzet 2025 * | 10,8 x |
K/w-verhouding 2024 * |
-5,04
x | K/w-verhouding 2025 * |
-6,69
x | Werknemers | 155 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 80,15% |
Recentste transcriptie over Day One Biopharmaceuticals, Inc.
1 dag | -13,03% | ||
1 week | -16,13% | ||
Lopende maand | -20,04% | ||
1 maand | -12,05% | ||
3 maanden | -3,08% | ||
6 maanden | +34,11% | ||
Lopend jaar | -9,52% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Samuel Blackman
FOU | Founder | 55 | 01-11-18 |
Jeremy Bender
CEO | Chief Executive Officer | 52 | 01-09-20 |
Charles York
DFI | Director of Finance/CFO | 47 | 01-02-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
J. Garland
BRD | Director/Board Member | 55 | 17-08-21 |
Natalie Holles
BRD | Director/Board Member | 51 | 01-02-21 |
John A. Josey
BRD | Director/Board Member | 63 | 01-09-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.08% | 0 M€ | 0,00% | - | |
0.06% | 0 M€ | 0,00% | - | |
0.01% | 9 M€ | +5,51% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 13,21 | -13,03% | 3 759 705 |
24-04-24 | 15,19 | -8,71% | 4 624 175 |
23-04-24 | 16,64 | +8,19% | 6 704 886 |
22-04-24 | 15,38 | +2,81% | 667 084 |
19-04-24 | 14,96 | -5,02% | 1 380 169 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,52% | 1,33 mld. | |
+1,12% | 43,84 mld. | |
+6,77% | 41,68 mld. | |
+45,26% | 41,25 mld. | |
-11,96% | 27,04 mld. | |
+6,01% | 25,53 mld. | |
-24,92% | 18,18 mld. | |
-3,63% | 12,29 mld. | |
+27,16% | 12,29 mld. | |
+7,30% | 11,15 mld. |